FDA Inspection 1215859 — DoubleDay Acquisitions
The FDA completed an inspection of DoubleDay Acquisitions on July 25, 2023 in Monroe, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 25, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Monroe, OH (United States)